Wybierz region

Advanta V12 balloon expandable covered stent

Kiss with confidence [1][2][3][5][7][12]

Advanta V12 is now EU MDR approved to treat occlusive lesions at the aortic bifurcation in a kissing configuration.[2]

Evidence spanning over 15 years has shown that using the kissing stent technique at the aortic bifurcation treats complex aortoiliac lesions, resulting in technical success, symptom improvement, and sustained patency.[2][5][7][12]

Balloon expandable covered stent.
Conformable, deliverable, flexible. Designed to track through tortuous arteries and flex to accommodate the iliac and renal anatomy.
Advanta V12 Balloon Expandable Covered Stent

Advanta V12 balloon expandable covered stent

Advanta V12 is the first to market balloon expandable, fully encapsulated stent that has served physicians with more than 850,000 units sold. Known for its precision and predictability – the versatile Advanta V12 covered stent has been meeting the needs of surgeons and patients for 20 years, and is the only durable solution backed by decades of real-world evidence.[1][2][3]

Indications:

The Advanta V12 covered stent system is indicated for treating patients diagnosed with renal artery stenosis and/or aortoiliac occlusive disease, including lesions at the aortic bifurcation, when endovascular therapy is required. In Canada, the Advanta V12 covered stent system indication excludes renal arteries.[2]

The Advanta V12 Balloon Expandable Covered Stent is not available in the U.S.

 

 

The predictability and precision you need for covered stent placement. [2][6][7][9][13]

Versatility to adapt to different treatment needs, with flexibility to conform to the anatomy.[1][2][4][8]

Predictable & Precise

  • Low profile, reliable stent retention, and secure trackability facilitate stent implantation [2]
  • 6 and 7 French compatible on 5-10 mm sizes. 6 French compatible with most
    common renal sizes.[2]
  • Predictable recoil and foreshortening promotes precise deployment [2]
  • Full encapsulation with ePTFE helps mitigate the risks related to vessel perforation [2][6][9][13]
  • Radiopaque markers enhance visibility during deployment and assist with accurate stent placement [2]
  • Dog‐bone inflation design is intended  to reduce the chances of embolization [7]
Group of stents

Versatile & Flexible

  • Stent structure, cell design, and system provide versatility and flexibility in delivery and placement [2]
  • Designed for pushability and trackability through tortuous anatomy with conformance to iliac and renal arteries [2]
  • Able to post-dilate and flare stent: conforming to the anatomy and customizing each patient's treatment [1][2][8]
  • Smooth inner lumen offers ease of navigation during re-intervention [2]
Advanta large diameter

Large Diameter

  • 12mm large diameter stents with 9 Fr compatibility offers increased treatment options and direct access to aorto-iliac anatomy [2][4]
  • Expands from 12 to 16 mm [2]

* Please see the Advanta V12 order information found in the documents tab for detailed compatibility.
Refer to Instructions for Use for current indications, warnings, contraindications and precautions.

Kiss with confidence [1][2][3][5][7][12]

Optimized patient outcomes today, tomorrow and into the future. [1][2][3][4][5][10][11]

  • Published literature over the last 20 years supports safety and performance[1][3][4][5][10]
  • Proven two-fold lower reintervention compared to bare metal stents at 5 years post-procedure[1]
  • Full encapsulation with ePTFE minimizes neointimal hyperplasia formation[2][11]
  • 316L stainless steel struts provide additional radial force, designed to support the stent patency[2]

COBEST - 5 year results: Advanta V12 vs. Bare Metal Stent [1]

  • Significantly higher patency in complex TASC C&D lesions compared to bare metal stents at 5 years (p=0.003).

Systematic review of covered balloon-expandable stents for treating aortoiliac occlusive disease [3]

  • The Advanta V12/iCast balloon expandable covered stent has long-term, real-world follow-up, including a reported 5-year primary patency rate of 74.7%.
  • The Advanta V12/iCast was the most common device studied in the literature from 2000-2019 (10/15 publications; 66.7%).
  • The Advanta V12/iCast studies treated patients with more severe disease (a greater number of TASC C&D lesions) and more severe symptoms (more Rutherford classification 4 & 5) compared to patients enrolled in clinical trials studying other covered balloon expandable stents.
  • Freedom from TLR: Results were comparable for all covered balloon expandable stents at 1 year. The Advanta V12/iCast has long-term target lesion revascularization data.
Journal of Vascular Surgery

iCARUS: Single-Arm IDE study with 3-year follow-up [4]

 

 

  • Real-world patient population with multiple lesions and bilateral disease​.
  • Study showed sustained clinical benefit with freedom from Target Lesion Revascularization (TLR) up to 3 years. 

Kissing Stent deployment for aortoiliac occlusive disease with Advanta V12

Bilateral iliac artery occlusion

Bilateral Iliac artery occlusion - pre restoration

Pre treatment

Bilateral Iliac artery occlusion - post restoration

Post treatment

Restoration of lumen diameter with Advanta V12 Kissing Stents. 10 x 38 mm Advanta V12 in the RIA; 10 x 59 mm Advanta V12 stents overlapped in LIA.

RIA - Right Iliac Artery, LIA - Left Iliac Artery

Bilateral common iliac artery occlusion

Bilateral Common Iliac artery occlusion - pre restoration

Pre treatment

Bilateral Common Iliac artery occlusion - post restoration

Post treatment

Restoration of the lumen diameter with 8x59 mm Advanta V12 Kissing Stents in RIA and LIA. 

RIA - Right Iliac Artery, LIA - Left Iliac Artery

Treatment of renal artery occlusive disease with Advanta V12

Renal artery stenosis

Renal artery stenosis - pre restoration

Pre treatment

Renal artery stenosis - post restoration

Post treatment

Restoration of the lumen diameter with Advanta V12 covered stents in LRA.

LRA - Left Renal Artery

eIFU portal

See our Instructions for Use

  1. 1. Mwipatayi, B.P., et al., Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. Journal of Vascular Surgery, 2016

    View on PubMed
  2. 2. Both Advanta V12 and iCast covered stent systems are manufactured by Atrium Medical Corporation. Advanta V12 is available outside of the United States. iCast is available only in the United States. Both products are the same physical stent and delivery system under different brands. Duration of use, number of units, and publications are combined Advanta V12 and iCast records. Data on file.

  3. 3. Mwipatayi, B.P., et al., A systematic review of covered balloon-expandable stents for treating aorto-iliac occlusive disease. Journal of Vascular Surgery, 2020.

    View on PubMed
  4. 4. Laird et al., iCAST Balloon-Expandable Covered Stent for Iliac Artery Lesions: 3-Year Results from the iCARUS Multicenter Study. Journal of Vascular and Interventional Radiology, 2019

    View on Pub Med
  5. 5. Sabri S, et al., Outcomes of Covered Kissing Stent Placement Compared with Bare Metal Stent Placement in the Treatment of Atherosclerotic Occlusive Disease at the Aortic Bifurcation. Journal of Vascular and Interventional Radiology, 2010

    View on PubMed
  6. 6. Al-Mukhaini et al., Coronary perforation and covered stents: an update and review. The Official Journal of the Gulf Heart Association; Heart Views, 2011

    View on PubMed
  7. 7. Grimme et al., Polytetrafluoroethylene Covered Stent Placement for Focal Occlusive Disease of the Infrarenal Aorta. Eur J Vasc Endovasc Surg, 2014

    View on PubMed
  8. 8. van der Riet et al., Three-Dimensional Geometric Analysis of Balloon-Expandable Covered Stents Improves Classification of Complications after Fenestrated Endovascular Aneurysm Repair. J of Clinical Medicine, 2022

    View on PubMed
  9. 9. Feldman DN, Armstrong EJ, Aronow HD, et al. SCAI guidelines on device selection in aorto-iliac arterial interventions. Catheter Cardiovasc Interv. 2020;96(4):915–929

    View on PubMed
  10. 10. Harris W., et al., Covered stents convey improved performance over bare metal stents for artherosclerotic renal artery stenosis. J Vasc Surg, 2013.

    View abstract on JVS
  11. 11. Rogers C, et al., Non-GLP study of biologic responses to uncoated and PTFE coated steel stents in rabbit iliac arteries. MIT iCast IH Study, 1997.

    View abstract on JACC
  12. 12. Boulitrop, C., et al., From the Aortic Bifurcation to the Groin: Long-term Outcomes of Covered Kissing Stent Placement in Combination with Iliofemoral Reconstruction for Extensive Iliofemoral Occlusive Disease. Annals of Vascular Surgery, 2020. 64: p. 11-16.

    View abstract on PubMed
  13. 13. Dubosq, M. and R. Coscas, The Iliacs and the Odyssey of Covered vs. Bare Metal Stents. European Journal of Vascular and Endovascular Surgery, 2023. 65(3):

    View on PubMed